000 01202 a2200337 4500
005 20250513175429.0
264 0 _c19990520
008 199905s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(98)04835-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBaltzan, M A
245 0 0 _aHip fractures attributable to corticosteroid use. Study of Osteoporotic Fractures Group.
_h[electronic resource]
260 _bLancet (London, England)
_cApr 1999
300 _a1327 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdministration, Oral
650 0 4 _aAdrenal Cortex Hormones
_xadministration & dosage
650 0 4 _aAged
650 0 4 _aBone Density
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aHip Fractures
_xchemically induced
650 0 4 _aHumans
700 1 _aSuissa, S
700 1 _aBauer, D C
700 1 _aCummings, S R
773 0 _tLancet (London, England)
_gvol. 353
_gno. 9161
_gp. 1327
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(98)04835-1
_zAvailable from publisher's website
999 _c10177705
_d10177705